# Phio Pharmaceuticals Corp.: Form 8-K, filed Feb 3, 2017

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2017-02-03
- Accepted by EDGAR: Feb 3, 2017, 17:25 ET
- Period: 2017-02-02
- Accession: 0001193125-17-030905
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312517030905/d328502d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312517030905/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312517030905/d328502d8k.htm

Filed Feb 3, 2017.
Source: SEC EDGAR, the filing index for accession 0001193125-17-030905. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
